Every Form 4 that Acadia Healthcare Company, Inc. (ACHC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ACHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACHC filings page.
Acadia Healthcare Company, Inc. executive Brian Farley, EVP, CLAO and Secretary, reported a disposition of 1,770 shares of common stock on 2026-07-26 in a transaction coded F, covering exercise-price or tax-liability obligations at $34.51 per share. After this withholding event, he directly holds 135,982 shares.
Acadia Healthcare Company, Inc. executive Brian Farley reported a routine tax-related share disposition. On this Form 4, Farley had 1,370 shares of Common Stock withheld at a price of $26.24 per share to cover tax obligations, a transaction classified as a tax-withholding disposition rather than an open-market sale. After this event, he continues to hold 137,752 shares of Acadia Healthcare Common Stock directly.
Fucci Michael reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director Michael Fucci received a grant of 6,331 shares of common stock as compensation. The shares were awarded at no cash cost to him and will vest over a three-year period in equal yearly installments beginning on May 6, 2027. After this grant, he directly holds a total of 28,152 shares of Acadia Healthcare common stock. This is a routine equity award rather than an open-market purchase or sale.
Acadia Healthcare Company, Inc. director Ralph David Kelly received a grant of 6,331 shares of Common Stock on May 6, 2026. The award carries no cash purchase price and represents a grant, award, or other acquisition of shares. These shares will vest over three years in equal yearly installments beginning May 6, 2027. Following this grant, Kelly directly holds 26,358 shares of Acadia Healthcare common stock.
Gregg Vicky B reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director Vicky B. Gregg reported receiving a stock award of 6,331 shares of common stock on May 6, 2026. The grant was at no cash cost per share and increased her direct holdings to 42,628 shares after the transaction. According to the filing, these awarded shares will vest over three years in equal yearly installments beginning May 6, 2027, meaning portions of the grant become available gradually rather than all at once.
Bernhard Jason reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director Jason Bernhard reported two stock awards of common stock on May 6, 2026. The filings show grants of 5,124 shares and 6,331 shares at a stated price of $0.00 per share, indicating compensation awards rather than open-market purchases.
Footnotes explain that the shares will vest over a three-year period in equal yearly installments beginning May 6, 2027, and that one award reflects Mr. Bernhard’s election to receive his 2026 annual cash retainer as a director in shares of common stock.
GRIECO WILLIAM reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director William Grieco received an equity grant of 6,331 shares of Common Stock as compensation. The shares were awarded at no cash cost to him and increase his directly held stake to 96,212 shares.
The granted shares will vest over three years in equal yearly installments beginning on May 6, 2027, meaning he earns the shares gradually over time as service continues on the board.
Cancelmi Daniel J reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director Daniel J. Cancelmi received a grant of 6,331 shares of common stock as reported on a Form 4. The award carried a stated price of $0.00 per share and is compensation-related rather than an open-market purchase or sale.
According to the disclosure, these shares will vest over a three-year period in equal annual installments beginning on May 6, 2027. Following this grant, Cancelmi directly holds a total of 12,956 Acadia Healthcare common shares, reflecting his updated equity stake as a company director.
Harris Patrice A reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director Patrice A. Harris reported receiving a grant of 6,331 shares of Common Stock as compensation. The award was recorded at a price of $0.00 per share and increased her directly held stake to 17,914 shares.
The granted shares will vest over three years in equal yearly installments beginning on May 6, 2027, meaning the award is subject to continued service or other vesting conditions rather than being fully owned immediately. This filing reflects a routine equity compensation grant, not an open-market purchase or sale.
WAUD REEVE B reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director Reeve B. Waud reported equity compensation in the form of common stock. On May 6, 2026, he received two stock awards of 9,576 shares and 6,331 shares at a price of $0.00 per share, including shares received in lieu of his 2026 annual cash director retainer. The shares will vest over a three-year period in equal yearly installments beginning May 6, 2027. Following these awards, Waud directly holds 75,859 shares. He is also reported as indirectly holding 653,015 shares through various trusts and Waud Capital Partners, L.L.C., while expressly disclaiming beneficial ownership except to the extent of his pecuniary interest.
Acadia Healthcare Company, Inc. director Bissell E. Perot reported compensation-related stock awards rather than open‑market trades. On May 6, 2026, he acquired 5,500 shares of common stock at no cash cost as a grant that will vest over three years in equal annual installments beginning May 6, 2027.
He also acquired an additional 6,331 shares of common stock at no cash cost, reflecting his election to receive his 2026 annual cash retainer as a director in shares instead of cash. Both transactions are classified as grants or awards, not market purchases or sales.
Acadia Healthcare Company, Inc. executive Brian Farley, EVP, CLAO and Secretary, reported a routine tax-related share disposition. On this Form 4, 5,063 shares of common stock were withheld at $27.69 per share to cover tax obligations, rather than sold on the open market. After this tax-withholding disposition, Farley directly holds 139,122 shares of Acadia Healthcare common stock.
Acadia Healthcare Company, Inc. executive Brian Farley, EVP, CLAO and Secretary, reported an equity award of common stock. He acquired 37,510 shares of common stock at $0.00 per share as a grant classified as a “grant, award, or other acquisition.”
These shares will vest over three years in equal yearly installments beginning on April 10, 2027, so the award is subject to a multi‑year service-based schedule. Following this grant, Farley directly holds 144,185 shares of Acadia Healthcare common stock. This is a compensation-related grant rather than an open-market trade.
YOUNG TODD S. reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. Chief Financial Officer Todd S. Young reported a compensation-related equity grant of 58,799 shares of common stock on April 10, 2026. The shares were granted at no cash cost to him and are scheduled to vest over three years in equal yearly installments beginning on April 10, 2027. After this award, he directly holds a total of 107,244 common shares, showing this is a sizable but routine stock-based compensation grant rather than an open-market purchase.
Farley Brian reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. reported that EVP, General Counsel and Secretary Brian Farley received a grant of 37,510 shares of common stock on April 10, 2026. The award was granted at no cash cost per share and is part of his equity compensation.
The shares will vest over a three-year period in equal yearly installments beginning on April 10, 2027, tying the benefit to continued service. After this award, Farley directly holds a total of 106,675 shares of Acadia Healthcare common stock.
Cancelmi Daniel J reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director Daniel J. Cancelmi received a grant of 6,625 shares of common stock as equity compensation. The shares were awarded at no cash cost and are held directly. They will vest over a three-year period in equal annual installments beginning on March 12, 2027, so Cancelmi must remain eligible over time to receive the full amount. Following this grant, he holds 6,625 shares of Acadia Healthcare common stock.
Acadia Healthcare Company, Inc. executive Brian Farley reported a Form 4 showing a tax-related share disposition. On this date, he disposed of 1,915 shares of common stock at a price of $22.29 per share to cover tax withholding obligations, leaving him with 69,165 shares held directly.
Acadia Healthcare Company, Inc. granted Chief Executive Officer and director Debra K. Osteen a stock option on January 20, 2026 covering 1,125,000 shares of common stock. The option has an exercise price of $11.68 per share, expires on January 20, 2036, and was awarded at a price of $0 for the derivative itself.
The vesting is performance- and time-based. 250,000 shares vest when the 30‑day share price VWAP reaches at least $25.00, another 250,000 at a VWAP of $35.00, and another 250,000 at a VWAP of $45.00. Three additional tranches of 125,000 shares each vest on the later of achieving the corresponding VWAP hurdle and January 20, 2027.
Acadia Healthcare (ACHC) reported an insider equity award for its Chief Financial Officer, Todd S. Young. On 10/27/2025, he acquired 48,445 shares of common stock at $0.00 per share. According to the filing, these shares will vest over three years in equal annual installments beginning 10/27/2026. Following this transaction, Young beneficially owned 48,445 shares, held directly.